Skip to main navigation Search Progenity Home Contact IR News & Events Financials Stock Governance Resources Press Releases Investor Relations News & Events Press Releases Press Releases Events & Presentations Year All Years Date Title November 23, 2021 Progenity Strengthens its Liquidity Position November 15, 2021 Progenity to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference November 10, 2021 Progenity Provides Corporate Update and Reports Third Quarter 2021 Financial Results November 9, 2021 Progenity Appoints Adi Mohanty as Chief Executive Officer November 4, 2021 Progenity Announces Appointment of Jill Howe to its Board of Directors November 3, 2021 Progenity to Report Third Quarter 2021 Financial Results and Provide Corporate Update October 26, 2021 Progenity Reduces Outstanding Debt by $20.175 Million Through a Private Exchange of $20.175 Million of Its 7.25% Convertible Senior Notes Due 2025 for Shares of Common Stock October 19, 2021 Progenity to Participate in Crohn’s & Colitis Foundation’s Fourth Annual IBD Innovate Conference October 13, 2021 Progenity Announces Several Patents Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Ingestible Therapeutics Technologies October 6, 2021 Progenity Announces Closing of $20 Million Registered Direct Offering of Common Stock Priced at Premium to Market Under Nasdaq Rules Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last » Displaying 1 - 10 of 97 Shareholder Tools Print This Page View RSS Feeds Get Email Alerts Contact IR Search the Site Connect With Us Company About Progenity Careers at Progenity Compliance Leadership Privacy & Terms of Use Innovation Preecludia™ Gastrointestinal Health Oral Biotherapeutics Publications Gastrointestinal Health Preeclampsia Investors News & Events Stock Information Corporate Governance Financials & Filings IR Resources © 2021 Progenity, Inc. All rights reserved. Progenity® is a registered service mark of Progenity, Inc. Preecludia™ is a trademark of Progenity, Inc. All other trademarks are the property of their respective owners. Please review our updated Website Privacy Policy, which describes our practices related to the collection, use, and disclosure of your personal information. For more information about how to opt-out of non-essential cookies for specific platforms, please view our Website Privacy Policy or Cookie Policy. Accept